Guo, Z.; Ding, Y.; Wang, M.; Zhai, Q.; Liu, J.; Du, Q.
Comparing the Differences in Adverse Events among Chimeric Antigen Receptor T-Cell Therapies: A Real-World Pharmacovigilance Study. Pharmaceuticals 2024, 17, 1025.
https://doi.org/10.3390/ph17081025
AMA Style
Guo Z, Ding Y, Wang M, Zhai Q, Liu J, Du Q.
Comparing the Differences in Adverse Events among Chimeric Antigen Receptor T-Cell Therapies: A Real-World Pharmacovigilance Study. Pharmaceuticals. 2024; 17(8):1025.
https://doi.org/10.3390/ph17081025
Chicago/Turabian Style
Guo, Zihan, Yunlan Ding, Mengmeng Wang, Qing Zhai, Jiyong Liu, and Qiong Du.
2024. "Comparing the Differences in Adverse Events among Chimeric Antigen Receptor T-Cell Therapies: A Real-World Pharmacovigilance Study" Pharmaceuticals 17, no. 8: 1025.
https://doi.org/10.3390/ph17081025
APA Style
Guo, Z., Ding, Y., Wang, M., Zhai, Q., Liu, J., & Du, Q.
(2024). Comparing the Differences in Adverse Events among Chimeric Antigen Receptor T-Cell Therapies: A Real-World Pharmacovigilance Study. Pharmaceuticals, 17(8), 1025.
https://doi.org/10.3390/ph17081025